ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,561.36
      -0.05%
      US Tech 100
      19,272.80
      -0.10%
      Dow Jones
      40,395.80
      -0.06%
      Brent Oil
      80.635
      -1.08%
      Bitcoin
      65,588.83
      -2.98%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Passage Bio Inc (PASG) Quote

      Passage Bio Inc

      Passage Bio Inc (PASG)

      NASDAQ
      0.821
      -0.047
      ( -5.41% )
      Updated: 15:37:33
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      0.821
      Bid
      0.8209
      Ask
      0.846
      Volume
      132,572
      0.8092 Day's Range 0.8998
      0.5751 52 Week Range 1.79
      Market Cap
      50.607M
      Previous Close
      0.868
      Open
      0.8779
      Last Trade
      100
      @
      0.821
      Last Trade Time
      15:37:33
      Financial Volume
      $ 110,961
      VWAP
      0.836989
      Average Volume (3m)
      134,738
      Shares Outstanding
      61,640,596
      Dividend Yield
      -
      PE Ratio
      -0.50
      Earnings Per Share (EPS)
      -1.66
      Revenue
      -
      Net Profit
      -102.06M

      About Passage Bio Inc

      Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.passagebio.com/home/default.aspx
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Passage Bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker PASG. The last closing price for Passage Bio was $0.87. Over the last year, Passage Bio shares have traded in a share price range of $ 0.5751 to $ 1.79.

      Passage Bio currently has 61,640,596 shares outstanding. The market capitalization of Passage Bio is $53.50 million. Passage Bio has a price to earnings ratio (PE ratio) of -0.50.

      PASG Latest News

      More News

      Form 8-K - Current report

      July 16 2024
      Edgar (US Regulatory)

      Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patients

      Agency feedback from Type C meeting process supports the company's proposed clinical development plans to expand the upliFT-D trial to assess PBFT02 in FTD patients with C9orf72 gene mutations...

      July 16 2024
      GlobeNewswire Inc.

      Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference

      PHILADELPHIA, June 05, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative...

      June 05 2024
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      May 23 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      May 22 2024
      Edgar (US Regulatory)

      Passage Bio Announces Recipient of Third Annual Tachi Yamada Scholarship Award

      PHILADELPHIA, May 21, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative...

      May 21 2024
      GlobeNewswire Inc.

      Form 424B3 - Prospectus [Rule 424(b)(3)]

      May 14 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      May 14 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      May 14 2024
      Edgar (US Regulatory)

      Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights

      Updated interim data from the upliFT-D trial in FTD-GRN demonstrated that Dose 1 PBFT02 achieved consistent elevation of CSF progranulin at six months post-treatment in the two patients with...

      May 14 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.089-9.780219780220.910.98070.80923836870.93472276CS
      4-0.109-11.72043010750.931.030.791707730.91614663CS
      12-0.489-37.32824427481.311.640.791347381.09764038CS
      26-0.079-8.777777777780.91.790.792419361.2958253CS
      52-0.179-17.911.790.57513237280.98368306CS
      156-11.829-93.509881422912.6513.430.57513113272.8836132CS
      260-21.449-96.313426133822.2738.230.57513064447.93419254CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      DCAPUnity Wealth Partners Dynamic Capital Appreciation & Options ETF
       20.10
      (839.25%)
      		128.77k
      RGCRegencell Bioscience Holdings Ltd
      $ 18.66
      (453.71%)
      		1.11M
      SLRXSalarius Pharmaceuticals Inc
      $ 2.66
      (72.73%)
      		59.28M
      ALPPAlpine 4 Holdings Inc
      $ 0.8296
      (72.29%)
      		2.32M
      ADILAdial Pharmaceuticals Inc
      $ 1.48
      (39.62%)
      		158.31M
      FLYEFly E Group Inc
      $ 1.0302
      (-83.85%)
      		23.02M
      RNAZTransCode Therapeutics Inc
      $ 0.2991
      (-62.26%)
      		9.1M
      JAGXJaguar Health Inc
      $ 1.7201
      (-59.72%)
      		14.66M
      IVPInspire Veterinary Partners Inc
      $ 4.74
      (-48.70%)
      		1.41M
      MIRAMIRA Pharmaceuticals Inc
      $ 2.67
      (-46.71%)
      		24.84M
      SPWRSunPower Corporation
      $ 0.9558
      (33.53%)
      		178.53M
      SLNASelina Hospitality PLC
      $ 0.0264
      (-28.65%)
      		158.33M
      ADILAdial Pharmaceuticals Inc
      $ 1.48
      (39.62%)
      		158.31M
      NVDANVIDIA Corporation
      $ 122.845
      (-0.56%)
      		141.07M
      HOLOMicroCloud Hologram Inc
      $ 0.5501
      (17.95%)
      		113.04M

      PASG Discussion

      View Posts
      Monksdream Monksdream 3 weeks ago
      There are close to 1,000 listed med tech companies
      Only so many can garner serious institutional interest
      👍️0
      PonkenPlonken PonkenPlonken 3 weeks ago
      I wonder... when will people realize that the AAV stuff is great... CADL, SLDB, PASG

      The founder certainly thinks so... and he is the authority on the topic:
      "Dr. James M. Wilson serves as the Director of the Gene Therapy Program (GTP) at Penn's Perelman School of Medicine."

      "The Wilson lab identified a new type of vector based on novel isolates of adeno-associated viruses which have become best in class for gene therapy. More recently Dr. Wilson’s laboratory has focused on improved vectors for gene therapy and clinical applications of genome editing and mRNA therapy.The Wilson lab identified a new type of vector based on novel isolates of adeno-associated viruses which have become best in class for gene therapy. More recently Dr. Wilson’s laboratory has focused on improved vectors for gene therapy and clinical applications of genome editing and mRNA therapy."
      👍️0
      Monksdream Monksdream 2 months ago
      PASG under $2
      👍️0
      Monksdream Monksdream 3 months ago
      PASG under $2
      👍️0
      Sirpeter Sirpeter 4 months ago
      Running... boom!!!
      👍️0
      Monksdream Monksdream 4 months ago
      PASG under $2
      👍️0
      glenn1919 glenn1919 4 months ago
      PASG..........................https://stockcharts.com/h-sc/ui?s=PASG&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 5 months ago
      PASG new 52 week high
      👍️0
      TrendTrade2016 TrendTrade2016 5 months ago
      PASG setting up nicely. Another beautiful call by the only true chartist around
      👍️0
      Sirpeter Sirpeter 5 months ago
      Yup yup yup...
      👍️0
      TrendTrade2016 TrendTrade2016 5 months ago
      PASG...NEXT CRDL
      👍️0
      glenn1919 glenn1919 5 months ago
      PASG..............................https://stockcharts.com/h-sc/ui?s=PASG&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 5 months ago
      PASG..............................https://stockcharts.com/h-sc/ui?s=PASG&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 5 months ago
      PASG under $2
      👍️0
      turning stone turning stone 6 months ago
      As a new investor in PASG, I am looking forward to another high roller in the next number of years. I bought ARNA years ago at 1.90 and rode it out to $99/share when they were bought out by Phizer Pharm. I would like to have my 5 grandkids share the spoils on this one. With a multi-pipe line, a couple should make it to the end of the line with FDA approval. At the number of shares I purchased multiple times I can afford to run for the hills if a sudden disaster should hit this one. This company is 21 miles from my home and I will stop by shortly and have a sit down with their home-based PR. person. Good luck to all. You may also want to look at BLRX {BIO-Line Inc }










      👍️0
      Walter4 Walter4 7 months ago
      Data readout should be incoming shortly
      👍️ 1
      Monksdream Monksdream 11 months ago
      PASG new 52 week low
      👍️0
      catinhat catinhat 2 years ago
      So...anybody out there? Thoughts on upcoming abstract, etc?

      Recent long.
      👍️0
      dealerschool2006 dealerschool2006 3 years ago
      PASG down from panic selling due to the pricing of its underwritten public offering of 7,000,000 shares of its common stock at a public offering price of $22.00 per share.
      👍️0

      Your Recent History

      NASDAQ
      PASG
      Passage Bio
      BOV
      PRIO3Q
      PETRORIO ON
      Delayed Upgrade Clock